ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AGR Assura Plc

40.64
-0.26 (-0.64%)
Last Updated: 15:54:36
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Assura Plc LSE:AGR London Ordinary Share GB00BVGBWW93 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.26 -0.64% 40.64 40.56 40.66 41.70 40.50 41.70 3,437,629 15:54:36
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Real Estate Agents & Mgrs 150.4M -119.2M -0.0402 -10.10 1.2B

Assura PLC Trading Update (5416D)

01/02/2018 7:00am

UK Regulatory


Assura (LSE:AGR)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Assura Charts.

TIDMAGR

RNS Number : 5416D

Assura PLC

01 February 2018

1 February 2018

Assura plc

Trading Update

For the third quarter to 31 December 2017

GBP310m capital raised and promptly deployed

Assura plc ("Assura"), the UK's leading primary care property investor and developer, today publishes a trading update for the third quarter to 31 December 2017.

Value enhancing investment and development activity

We continued to make good progress in the third quarter, completing the acquisition of 22 medical centres and one development under a forward funding agreement at a combined cost of GBP84 million. These additions have a combined passing rent roll of GBP4.1 million and a weighted average unexpired lease length of 13.5 years.

Rental income increased

Assura now owns 498 medical centres with a total annualised rent roll of GBP87.4 million (30 September 2017: GBP83.1 million), with growth in the financial year to date driven primarily by acquisitions.

Secure and growing dividend

A key part of Assura's strategy is providing a secure, fully covered and growing dividend stream for investors. The quarterly dividend was increased by 9% for the January 2018 payment to 0.655 pence per share, equivalent to 2.62 pence per share on an annualised basis.

Financial position strengthened and capital deployed

In October 2017, Assura issued GBP150 million of unsecured eight and ten-year notes at a fixed rate of 3.04% and extended the Revolving Credit Facility by a further GBP50 million to GBP300 million.

In December 2017, Assura successfully raised a further GBP310 million from both existing and new investors, reflecting the strong support for our growth strategy. This capital has been swiftly deployed with GBP84 million of assets purchased by the end of December 2017 and in January 2018, we redeemed the Aviva secured debt of GBP211 million plus early repayment costs of GBP56 million.

Following this, gross debt stood at GBP430 million with undrawn facilities of GBP230 million.

Further details will be provided with the financial results for the year ended 31 March 2018, which are due to be released on 23 May 2018.

Market Background

GPs continue to highlight the challenges associated with a lack of space, poor layout and maintaining older buildings which are not fit for 21(st) century healthcare. As hospitals struggle to cope this winter, creating the infrastructure to allow more patients to be treated in the community is a key part of the solution. The autumn budget set out plans to invest GBP10 billion to make NHS buildings fit for the future, in line with the recommendations outlined in the Naylor Review, and we remain committed to playing our part. Assura joined with sector colleagues last summer to set out the potential for investment in primary care buildings through third party development, flagging that GBP3 billion could be invested over five years in the 'Primary Care Buildings Pledge'.

Jonathan Murphy, CEO, commented:

"Assura continued to make good progress in the third quarter, further diversifying its funding structure and investing in primary health care real estate. We remain confident in the outlook for the business for the full-year."

- Ends -

For more information, please contact:

 
 
  Assura plc       Tel: 01925 420660 
Jonathan Murphy 
 Jayne Cottam 
 Orla Ball 
 
  Edelman          Tel: 0203 047 2546 
John Kiely 
 Mav Wynn 
 Rob Yates 
 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community. At 30 September 2017, Assura's property portfolio was valued at GBP1,560 million.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association

This information is provided by RNS

The company news service from the London Stock Exchange

END

TSTLLFIDLLILVIT

(END) Dow Jones Newswires

February 01, 2018 02:00 ET (07:00 GMT)

1 Year Assura Chart

1 Year Assura Chart

1 Month Assura Chart

1 Month Assura Chart

Your Recent History

Delayed Upgrade Clock